Acambis related Press Releases
Acambis reports positive data from trials of universal influenza A vaccine
Acambis reports positive data from trials of universal influenza A vaccine Cambridge, UK and Cambridge, Massachusetts – 3 January 2008 – Acambis plc (Acambis) (LSE: ACM), a leading vaccine... Read more...
PRESS RELEASE: Acambis Joins Forces With Sanofi Pasteur to Develop West Nile Virus Vaccine
Acambis Joins Forces With Sanofi Pasteur to Develop West Nile Virus Vaccine CAMBRIDGE, England and CAMBRIDGE, Massachusetts, November 1 - No Human Vaccine Currently Exists Against the West Nile... Read more...
PRESS RELEASE: FDA Approves ACAM2000 Vaccine for Protection Against Smallpox
FDA Approves ACAM2000 Vaccine for Protection Against Smallpox CAMBRIDGE, England and CAMBRIDGE, Massachusetts, September 3 /PRNewswire-FirstCall/ -- Acambis plc (Acambis) , a leading vaccine company,... Read more...
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges




